COX‐2 inhibitors—implementation of the NICE guidelines

Saved in:
Bibliographic Details
Published inRheumatology (Oxford, England) Vol. 41; no. 5; pp. 590 - 592
Main Authors Bardell, E., Gordon, M.‐M., Porter, D.
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.05.2002
Oxford Publishing Limited (England)
Subjects
Adolescent
Adult
Aged
Aged, 80 and over
Anti-Inflammatory Agents, Non-Steroidal - adverse effects
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Cohort Studies
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors - adverse effects
Cyclooxygenase Inhibitors - therapeutic use
Drug Therapy, Combination
Hospitals, Teaching
Humans
Isoenzymes - antagonists & inhibitors
Membrane Proteins
Middle Aged
Practice Guidelines as Topic
Prostaglandin-Endoperoxide Synthases
Rheumatic Diseases - complications
Rheumatic Diseases - drug therapy
Surveys and Questionnaires
Online AccessGet full text

Cover

More Information
Bibliography:istex:573A46C3EFFE6BE668EC9FE6C6A6E5EEE2405DCD
ark:/67375/HXZ-3JBCMVMB-H
PII:1460-2172
local:410590
ISSN:1462-0324
1462-0332
DOI:10.1093/rheumatology/41.5.590